Dot enzyme-linked immunosorbent assay for more reliable staging of patients with human African trypanosomiasis

Journal of Clinical Microbiology

Volumn 43, Issue 9, 2005, Pages 4789-4795

  Courtioux, Bertrand ^a   Bisser, Sylvie ^b   M'Belesso, Pascal ^c   Ngoungou, Edgard ^a   Girard, Murielle ^a   Nangouma, Auguste ^d   Josenando, Théophile ^e   Jauberteau Marchan, Marie Odile ^f   Bouteille, Bernard ^a  

^a UNIVERSITÉ DE LIMOGES   (France)

^b CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^c Hopital de l'Amitie   (Central African Republic)

^d Programme National de Lutte Contre le Paludisme   (Central African Republic)

^e Instituto de Combate e Controlo das Tripanossomiases   (Angola)

^f UNIVERSITÉ DE LIMOGES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GALACTOCEREBROSIDE ANTIBODY; IMMUNOGLOBULIN M; NEUROFIBRIL ANTIBODY; PYROXYLIN; UNCLASSIFIED DRUG;

ADULT; AFRICAN TRYPANOSOMIASIS; ANTIBODY DETECTION; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; DOT ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRYPANOSOMA; VALIDATION PROCESS;

EID: 24744460740     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.9.4789-4795.2005     Document Type: Article

References (29)

1. Amevigbe, M. M. D., M. O. Jauberteau-Marchan, B. Bouteille, F. Doua, J. C. Breton, J. A. Nicolas, and M. Dumas. 1992. Human African trypanosomiasis: presence of antibodies to galactocerebrosides. Am. J. Trop. Med. Hyg. 47:652-662.
2. Anthoons, J. A., E. A. Van Marck, and P. L. Gigase. 1986. Autoantibodies to intermediate filaments in experimental infections with Trypanosoma brucei gambiense. Z. Parasitenkd. 72:443-452.
3. Ayed, Z., I. Brindel, B. Bouteille, N. Van Meirvenne, F. Doua, D. Houinato, M. Dumas, and M. O. Jauberteau. 1997. Detection and characterization of autoantibodies directed against neurofilament proteins in human African trypanosomiasis. Am. J. Trop. Med. Hyg. 57:1-6.
4. Bisser, S., V. Lejon, P. M. Preux, B. Bouteille, A. Stanghellini, M. O. Jauberteau, P. Büscher, and M. Dumas. 2002. Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness. J. Neurol. Sci. 193:127-135.
5. Bouteille, B., O. Oukem, S. Bisser, and M. Dumas. 2003. Treatment perspectives for human African trypanosomiasis. Fundam. Clin. Pharmacol. 17:171-181.
6. Buguet, A., S. Bisser, T. Josenando, F. Chapotot, and R. Cespuglio. 2005. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness. Acta Trop. 93:107-117.
7. Cattand, P., B. Miezan, and P. De Raadt. 1988. Human African trypanosomiasis: use of double centrifugation of cerebrospinal fluid to detect trypanosomes. Bull. W. H. O. 66:83-86.
8. Chappuis, F., L. Loutan, P. Simarro, V. Lejon, and P. Büscher. 2005. Options for field diagnosis of human African trypanosomiasis. Clin. Microbiol. Rev. 18:133-146.
9. Doua, F., T. W. Miezan, J. R. Sanon Singaro, F. Boa Yapo, and T. Baltz. 1996. The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis. Am. J. Trop. Med. Hyg. 55:586-588.
10. Dumas, M., and S. Bisser. 1999. Clinical aspect of human African trypanosomiasis, p. 215-249. In M. Dumas, B. Bouteille, and A. Buguet (ed.), Progress in human African trypanosomiasis, sleeping sickness. Springer-Verlag, Paris, France.
11. Girard, M., S. Bisser, P. Büscher, B. Bouteille, J. L. Preud'homme, and M. O. Jauberteau. 2000. Cross-reactivity of galactocerebroside autoantibodies with a Trypanosama brucei proteolipidic epitope. Clin. Exp. Immunol. 119:516-522.
12. Jamonneau, V., P. Solano, A. Garcia, V. Lejon, N. Dje, T. W. Miezan, P. N'Guessan, G. Cuny, and P. Büscher. 2003. Stage determination and therapeutic decision in human African trypanosomiasis: value of polymerase chain reaction and immunoglobulin M quantification on the cerebrospinal fluid of sleeping sickness patients in Cote d'Ivoire. Trop. Med. Int. Health 8:589-594.
13. Jannín, J., and P. Cattand. 2004. Treatment and control of human African trypanosomiasis. Curr. Opin. Infect. Dis. 17:565-571.
14. Jauberteau, M. O., S. Bisser, Z. Ayed, I. Brindel, B. Bouteille, A. Stanghellini, S. Gampo, S. Doua, J. C. Breton, and M. Dumas. 1994. The detection of anti-galactocerebroside autoantibodies in human African trypanosomiasis. Bull. Soc. Pathol. Exot. 87:333-336.
15. Kobayakawa, T., J. Louis, S. Izui, and P. H. Lambert. 1979. Autoimmune response to DNA, red blood cells, and thymocyte antigens in association with polyclonal antibody synthesis during experimental African trypanosomiasis. J. Immunol. 122:296-301.
16. Lejon, V., H. Reiber, D. Legres, N. Dje, E. Magnus, I. Wouters, C. J. Sindic, and P. Büscher. 2003. Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis. J. Infect. Dis. 187:1475-1483.
17. Lejon, V., D. Legros, M. Richer, J. A. Ruiz, V. Jamonneau, P. Truc, F. Doua, N. Dje, N'Siesi, F. X., S. Bisser, E. Magnus, I. Wouters, J. Konings, T. Vervoort, F. Sultan, and P. Büscher. 2002. IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test. Trop. Med. Int. Health 7:685-692.
18. Lejon, V., and P. Büscher. 2001. Stage determination and follow-up in sleeping sickness. Med. Trop. 61:355-360.
19. Lejon, V., P. Büscher, E. Magnus, A. Moons, I. Wouters, and N. Van Meirvenne. 1998. A semi-quantitative ELISA for detection of Trypanosoma brucei gambiense specific antibodies in serum and cerebrospinal fluid of sleeping sickness patients. Acta Trop. 69:151-164.
20. Llames, L., J. Goyache, A. Domenech, A. de Avila, G. Suarez, and E. Gomez-Lucia. 1999. Rapid detection of specific polyclonal and monoclonal antibodies against bovine leukemia virus. J. Virol. Methods 82:129-136.
21. MacKenzie, A. R., and P. F. Boreham. 1974. Autoimmunity in trypanosome infections. I. Tissue autoantibodies in Trypanosoma (Trypanozoon) brucei infections of the rabbit. Immunology 26:1225-1238.
22. Magnus, E., T. Vervoort, and N. Van Meirvenne. 1978. A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T. b. gambiense trypanosomiasis. Ann. Soc. Belge Med. Trop. 58:169-176.
23. Mattern, P. 1968. Current status and results of immunologic technics used at the Pasteur Institute of Dakar for the diagnosis and study of human African trypanosomiasis. Bull. W. H. O. 38:1-8.
24. Miezan, T. W., A. H. Meda, F. Doua, and P. Cattand. 1994. Evaluation des techniques parasitologiques utilisées dans le diagnostic de la trypanosomose humaine à Trypanosoma brucei gambiense en Côte-d'Ivoire. Bull. Soc. Pathol. Exot. 87:101-104.
25. Miezan, T. W., H. A. Meda, F. Doua, F. B. Yapo, and T. Baltz. 1998. Assessment of central nervous system involvement in gambiense trypanosomiasis: value of the cerebro-spinal white cell count. Trop. Med. Int. Health 3:571-575.
26. Pepin, J., F. Milord, and C. Guern. 1989. Human African trypanosomiasis and normality of the cerebrospinal fluid. Med. Trop. 49:29-31.
27. Pepin, J., and N. Khonde. 1996. Relapses following treatment of early-stage Trypanosoma brucei gambiense sleeping sickness with a combination of pentamidine and suramin. Trans. R. Soc. Trop. Med. Hyg. 90:183-186.
28. Porat, Y. B., I. Zan-Bar, and A. Ravid. 1995. Quantitative dot-blot assay for low titer anti-lipopolysaccharide antibodies in human plasma. J. Immunol. Methods 180:213-218.
29. World Health Organization. 1998. Control and surveillance of African trypanosomiasis. W.H.O. Technical Report Series, no. 881. World Health Organization, Geneva, Switzerland.